LABP Past Earnings image   This LABP past earnings page last updated 11/11/2022
LABP Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/10/2022-0.200
Q2 20228/11/2022-0.280
Q1 20225/12/2022-0.370
Q4 20213/24/2022-0.520
Q3 202111/15/2021-0.320
Q2 20217/29/20210.120
Q1 20215/17/2021-0.380
LABP Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/10/2022NA
Q2 20228/11/2022NA
Q1 20225/12/2022NA
Q4 20213/24/2022NA
Q3 202111/15/2021NA
Q2 20217/29/20210.02B
Q1 20215/17/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree LABP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Landos Biopharma (LABP) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

LBPH Past Earnings
LCI Past Earnings
LFST Past Earnings
LGND Past Earnings
LGVN Past Earnings
LH Past Earnings
LHCG Past Earnings
LHDX Past Earnings
LIFE Past Earnings
LIXT Past Earnings

LABP Past Earnings Q&A

What was the best and worst LABP past earnings results?
For Landos Biopharma, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest LABP past earnings result in our data set was 0.120/share posted in Q2 2021, while the lowest was in Q4 2021 when LABP posted -0.520/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2021 when LABP reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 7 LABP past earnings results in our data set.

On this page we presented the LABP past earnings date information for Landos Biopharma. Reviewing that LABP Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2021, when LABP posted gaap of 0.120/share. Meanwhile the lowest LABP past earnings result was in Q4 2021, when LABP posted gaap of -0.520/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2021 when LABP reported 0.02B in revenue, while the smallest revenue quarter was Q3 2022 when LABP reported NA in revenue.

Any self directed investor doing their due diligence on LABP or any other given stock can benefit from researching all of the Landos Biopharma past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Landos Biopharma past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LABP. Thanks for visiting, and the next time you need to research LABP past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: FleetCor Technologies shares outstanding history, Top Ten Hedge Funds Holding EMDG, NCIT Price Target.


LABP Past Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.